Hiperkalemi ve Kanıta Dayalı Tedavi Bakım Uygulamaları
Özet
Potasyum, hücre içi sıvının ana katyonudur. İnsan vücudunda potasyumun %98’i hücre içi sıvıda, %2’si hücre dışı sıvıda bulunur. Böbreklerde işleyen nefronların kaybı, distal tübüllerde akışın bozulması, hücre içi ve hücre dışı alandaki potasyumun dağılımındaki dengesizlikler, kullanılan ilaçlarla beraber potasyum kaybı ve yetersiz beslenme gibi durumlar potasyum atılımının bozulmasına neden olur. Özellikle hiperkalemi birçok komplikasyonu da beraberinde getirir. Hiperkalemi yönetimi için, diyet, ilaç tedavisi, böbrek fonksiyonlarının azalması ve interdiyalitik kilo yönetimi esas noktaları oluşturmaktadır.
Referanslar
Fishbane S, Charytan DM, Chertow GM, Ford M, Kovesdy CP, Pergola PE, Pollock C, Spinowitz B. Consensus-Based Recommendations for the Management of Hyperkalemia in the Hemodialysis Setting. Journal of Renal Nutrition,2022; Vol 32, No 4 (July), 2022: pp e1-e14
Kovesdy CP, Regidor DL, Mehrotra R, et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol. 2007; 2: 999–1007.
Pirklbauer M. Hemodialysis treatment in patients with severe electrolyte disorders: Management of hyperkalemia and hyponatremia. Hemodialysis International 2020; 24:282–289.
Renal Association Clinical Practice Guideline on Haemodialysis. https://pubmed.ncbi.nlm.nih.gov/31623578/
Lin J, Cheng Z, Ding X, Qian Q. Acid–base and electrolyte managements in chronic kidney disease and endstage renal disease: Case-based discussion. Blood Purif. 2018;45:179–186.
McGill RL, Weiner DE. Dialysate composition for hemodialysis: Changes and changing risk. Semin Dial. 2017;30:112–120.
Pun PH, Goldstein BA, Gallis JA, Middleton JP, Svetkey LP. Serum potassium levels and risk of sudden cardiac death among patients with chronic kidney disease and significant coronary artery disease. Kidney Int Rep. 2017;2:1122–1131.
Huang CW, Lee MJ, Lee PT, et al. Low potassium dialysate as a protective factor of sudden cardiac death in hemodialysis patients with hyperkalemia. PLoS One. 2015;10:e0139886.
Morris A&Lycett D. Behavioural strategies to self‐manage low‐potassium diets in chronic kidney disease, J Ren Care. 2021;47:160–168.
Hartmann‐Boyce, J., Aveyard, P., Koshiaris, C. & Jebb, S.A. (2016) Development of tools to study personal weight control strategies: Ox FAB taxonomy. Obesity, 24, 314–320.
Kwasnicka, D., Dombrowski, S.U., White, M. & Sniehotta, F. (2016) Theoretical explanations for maintenance of behaviour change: a systematic review of behaviour theories. Health Psychology Review, 10, 277–296.
Howren, M.B., Kellerman, Q.D., Hillis, S.L., Cvengros, J., Lawton, W. & Christensen, A.J. (2016) Effect of a behavioral self‐regulation intervention on patient adherence to fluid‐intake restrictions in hemodialysis: a randomized controlled trial. Annals of Behavioral Medicine, 50, 167–176.
Özkan İ&Taylan S. Diet and fluid restriction experiences of patients on hemodialysis: a meta-synthesis study. Rev Nefrol Dial Traspl. 2022;42(1):22-40)
Turban, S.; Juraschek, S.P.; Miller, E.R., 3rd; Anderson, C.A.M.; White, K.; Charleston, J.; Appel, L.J. Randomized Trial on the Effects of Dietary Potassium on Blood Pressure and Serum Potassium Levels in Adults with Chronic Kidney Disease. Nutrients 2021, 13, 2678.
Morris A, Lycett D. Experiences of the dietary management of serum potassium in chronic kidney disease: interviews with UK adults on maintenance hemodialysis. J Ren Nutr. 2020;30(6):556-60. doi: 10.1053/j.jrn.2020.01.025.
Martínez-Pineda, M.; Vercet, A.; Yagüe-Ruiz, C. Are Food Additives a Really Problematic Hidden Source of Potassium for Chronic Kidney Disease Patients? Nutrients 2021, 13, 3569).
Picard K. 2019, Potassium Additives and Bioavailability: Are We Missing Something in Hyperkalemia Management?. J of Renal Nutrition, 29(4):350-353.)
Garagarza, C.; Valente, A.; Caetano, C.; Ramos, I.; Sebastiao, J.; Pinto, M.; Oliveira, T.; Ferreira, A.; Sousa Guerreiro, C. Potassium Intake-(Un)Expected Non-Predictor of Higher Serum Potassium Levels in Hemodialysis DASH Diet Consumers. Nutrients 2022,14, 2071).
Narasaki, Y.; Okuda, Y.; Kalantar, S.S.; You, A.S.; Novoa, A.; Nguyen, T.; Streja, E.; Nakata, T.; Colman, S.; Kalantar-Zadeh, K.; et al. Dietary Potassium Intake and Mortality in a Prospective Hemodialysis Cohort. J. Ren. Nutr. 2021, 31, 411–420.
Batista, R.A.B.; Japur, C.C.; Prestes, I.V.; Fortunato Silva, J.; Cavanha, M.; das Graças Pena, G. Potassium reduction in food by preparation technique for the dietetic management of patients with chronic kidney disease: A review. J. Hum. Nutr. Diet. 2021, 34, 736–746).
de Abreu, D.B.V.; Picard, K.; Klein, M.R.S.T.; Gadas, O.M.; Richard, C.; Barreto Silva, M.I. Soaking to Reduce Potassium and Phosphorus Content of Foods. J. Ren. Nutr. 2023, 33, 165–171.
.Cupisti, A.; Kovesdy, C.P.; D’Alessandro, C.; Kalantar-Zadeh, K. Dietary Approach to Recurrent or Chronic Hyperkalaemia in Patients with Decreased Kidney Function. Nutrients 2018, 10, 261).
MacLaughlin HL, McAuley E, Fry J, Pacheco E, Moran N, Morgan K, Mcguire L, Conley M, Johnson DW, Ratanjee SK, Mason B. Re-Thinking Hyperkalaemia Management in Chronic Kidney Disease—Beyond Food Tables and Nutrition Myths: An Evidence-Based Practice Review. Nutrients 2024, 16, 3. https://doi.org/10.3390/nu16010003)
